We are live on
!
Find out more
OKSA
O'Keefe Stevens Advisory Portfolio holdings
AUM
$488M
1-Year Est. Return
56.91%
This Fund
S&P 500
This Quarter
Est. Return
+7.44%
1 Year Est. Return
+56.91%
3 Year Est. Return
+216.24%
5 Year Est. Return
+351.07%
10 Year Est. Return
–
AUM
$299M
AUM Growth
-$5.44M
(-1.8%)
Cap. Flow
-$21.9M
Cap. Flow
% of AUM
-7.34%
Top 10 Holdings %
Top 10 Hldgs %
64.06%
Holding
72
New
6
Increased
46
Reduced
8
Closed
3
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Perrigo
PRGO
|
+$3.92M |
| 2 |
Alibaba
BABA
|
+$3.84M |
| 3 |
AerCap
AER
|
+$3.83M |
| 4 |
Pfizer
PFE
|
+$736K |
| 5 |
Five Point Holdings
FPH
|
+$395K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$38.2M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$248K |
| 3 |
Amgen
AMGN
|
+$219K |
| 4 |
GE Aerospace
GE
|
+$216K |
| 5 |
IBM
IBM
|
+$212K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 39.3% |
| 2 | Financials | 17.41% |
| 3 | Real Estate | 10.57% |
| 4 | Materials | 7.33% |
| 5 | Healthcare | 7.22% |
Similar funds
HL
UOIF
KCM
ACM
SCA
GCM
PE
RF
O'Keefe Stevens Advisory's Q2 2024 Portfolio in Review
As of Q2 2024, O'Keefe Stevens Advisory held 72 positions worth $299M, down 1.8% from $305M the previous quarter. Its ten largest holdings account for 64% of the portfolio.
O'Keefe Stevens Advisory withdrew a net $21.9M in Q2 2024, closing 3 positions and reducing 8 holdings. Its most notable exit was Bristol-Myers Squibb, an estimated $248K position sold in full.
By sector, the portfolio is most concentrated in Technology at 39% of assets, down from 42% a quarter earlier, followed by Financials and Real Estate.
Against the trend, O'Keefe Stevens Advisory opened a new position in Perrigo worth $3.43M.
- O'Keefe Stevens Advisory's largest Q2 2024 buy was Perrigo: 133,441 shares worth $3.43M.
- O'Keefe Stevens Advisory added most to AerCap in Q2 2024, an estimated $3.83M increase.
- O'Keefe Stevens Advisory's biggest Q2 2024 reduction was NVIDIA, cutting an estimated $38.2M.
- O'Keefe Stevens Advisory fully exited Bristol-Myers Squibb in Q2 2024, selling an estimated $248K.
- O'Keefe Stevens Advisory's ten largest holdings make up 64% of its $299M portfolio in Q2 2024.
- O'Keefe Stevens Advisory opened 6 new positions and closed 3 in Q2 2024.
- O'Keefe Stevens Advisory's portfolio value fell 1.8% quarter-over-quarter to $299M.
Based on O'Keefe Stevens Advisory's 13F filing for Q2 2024, filed 10 Jul 2024.